Evidence map›Paper›PMID 29930179›Full record

ArticleBMJ case reports2018

Numb chin syndrome as a presenting symptom of diffuse large B-cell lymphoma with secondary myelofibrosis.

Arihant Jain, Sweta Rajpal, Man Updesh Singh Sachdeva, Pankaj Malhotra

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring the molecular mechanisms between lymphoma and myelofibrosis.American journal of translational research · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arihant JainDepartment of Clinical Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.ORCID http://orcid.org/0000-0001-9495-9789
Sweta RajpalDepartment of Clinical Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Man Updesh Singh SachdevaDepartment of Clinical Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pankaj MalhotraDepartment of Hematology and Internal Medicine, PGIMER, Chandigarh, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma that classically presents with rapidly enlarging lymph nodes. We present a 59-year-old man with unusual clinical presentation of numb chin syndrome (NCS) as the first symptom of disease. On evaluation, he was found to have diffuse extranodal skeletal involvement in the form of lytic-sclerotic lesions and minimal lymphadenopathy. Bone marrow biopsy revealed a poorly differentiated tumour with infarction and extensive myelofibrosis. This was subsequently proven to be DLBCL of germinal centre type on immunohistochemical stain. NCS should alarm the clinician to investigate for an advanced underlying malignancy. Extensive myelofibrosis, though described in carcinomas and low grade lymphomas, may also be seen in high grade DLBCL.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDiagnosis, DifferentialHumansHypesthesiaLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPositron Emission Tomography Computed TomographyPrimary MyelofibrosisRituximabTreatment OutcomeVincristineCyclophosphamideRituximabVincristineAnaesthesiacranial nervesmalignant and benign haematology

Identifiers

PMID29930179
PMCPMC6020869
OpenAlexW2809066709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.